Nicotinics, adverse reaction

The nurse should advise the patient taking nicotinic add to put the call light on if discomfort is experienced. Contact the primary health care provider before the next dose is due should this adverse reaction occur. If the patient is in severe discomfort, the nurse should contact the primary health care provider immediately. The nurse advises outpatients to contact their primary health care provider if these reactionsare severe or cause extreme discomfort. 

Lactation Nicotine passes freely into breast milk and has the potential for serious adverse reactions in nursing infants. 

Given its many adverse reactions, the safety of using nicotinic acid continues to be discussed. Some are of the opinion that it should only be given to patients with marked dyslipidemia and under close monitoring, and that the initial expectations of fewer adverse reactions... 

Adverse reactions to treatment with diethylcarbamazine vary with the infecting filarial species and are most severe in onchocerciasis. Minor reactions include malaise, nausea, and headache, but diethylcarbamazine also depresses the central nervous system in some individuals, resulting in dizziness and somnolence reversible coma has been reported in patients in poor physical condition. Nicotine-like properties can produce autonomic effects. A degree of eosinophilia during treatment is usual. 

Adverse reactions were mild in a controlled study of the efficacy of pentetrazol, alone and in combination with nicotinic acid, in 30 chronic hospitalized elderly patients. Improvement was better with the combined treatment, and only one subject, a 71-year-old woman, developed restlessness, anorexia, and weight loss (3). 

Adverse reactions Thiamine rare anaphylaxis after a large IV dose Riboflavin none known Niacin or nicotinic acid Cardiac arrythmias may occur rarely Pyridoxine Lxmg-term megadoses may produce sensory neuropathy... 

This drug has been studied for lipid reduction in 30 patients over a period of 30 and 60 days (28 ). Although the impression was gained that adverse reactions were much less pronounced in the initial phases of treatment than with nicotinic acid, this is a case where conclusions must be reserved until adequate clinical work has determined the equipotent clinical dose. 

Memantine is the first in a novel class of Alzheimer s disease medications acting a.o. on the NMDA receptor of the glutamatergic system. It also acts as an uncompetitive antagonist at different neuronal nicotinic receptors at potencies possibly similar to the NMDA receptor. Memantine is approved for treatment of moderate to severe Alzheimer s disease and its use is associated with a moderate decrease in clinical deterioration of the disease. Common adverse drug reactions (>1% of patients) include confusion, dizziness, drowsiness, headache, insomnia, agitation, and/or hallucinations. 

Acipimox is not associated with liver adverse drug reactions and should be safe to use. Niacin (nicotinic acid) has been reported to cause transient elevation in transaminases at high doses, as well as more serious... 

Local skin reactions to transdermal nicotine patches have been reported (31). Other local adverse effects, including erythema with edema, erosions, and systemic skin reactions have also been described (32). 

---